Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2000
03/07/2000US6034105 Alteration of circadian rhythmicity with a tachykinin antagonist
03/07/2000US6034097 Isoquinolines useful as analgesics
03/07/2000US6034094 Pharmaceutically useful 3,4-dihydroisoquinoline
03/07/2000US6034090 Therapy for nervous system, brain disorders
03/07/2000US6034085 Salt form of nefazodone for use in extended release formulations
03/07/2000US6034082 5-azabicyclo(3.1.0)hexylalkyl-2-piperiodones and --glutarimides as neurokinin receptor antagonists
03/07/2000US6034080 Alzheimer's disease
03/07/2000US6034077 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/07/2000US6034057 Cyclic octapeptide; antiarthritic agent
03/07/2000US6034056 Cyclic peptides; antiarthritic agents
03/07/2000US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
03/07/2000US6033872 Polynucleotides encoding a novel human 11cb splice variant
03/07/2000US6033869 Diagnosis, prevention, and treatment of disorders associated with aberrant cellular development and differentiation and inflammation.
03/07/2000CA2030401C Inhibition of the abstinence syndrome
03/02/2000WO2000011204A2 Homer interacting proteins
03/02/2000WO2000011169A2 Human cell signaling proteins (csig)
03/02/2000WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000WO2000011027A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
03/02/2000WO2000011014A1 49 human secreted proteins
03/02/2000WO2000011003A1 ISOXAZOLO[4,5-d]PYRIMIDINES AS CRF ANTAGONISTS
03/02/2000WO2000011001A1 Muscarinic agonists and antagonists
03/02/2000WO2000010997A1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010973A2 Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands
03/02/2000WO2000010968A2 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000WO2000010967A1 Novel aryl sulphonamides and analogues
03/02/2000WO2000010958A1 Vitamin d3 mimics
03/02/2000WO2000010611A2 Drug targeting
03/02/2000WO2000010572A1 Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
03/02/2000WO2000010567A1 Amelioration of apomorphine adverse effects
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010554A2 Methods and compositions employing optically pure s(+) vigabatrin
03/02/2000WO2000010553A2 Carbamate and urea compositions and neurotrophic uses
03/02/2000WO2000010551A2 Methods of using and compositions comprising dopamine reuptake inhibitors
03/02/2000WO2000010536A1 Extended release buccal bioadhesive tablet
03/02/2000WO2000010529A1 Oral liquid mucoadhesive compositions
03/02/2000WO2000010528A1 Oral liquid mucoadhesive compositions
03/02/2000WO1999064059A3 Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
03/02/2000WO1999061614A3 Human socs proteins
03/02/2000WO1999058642A3 Secreted proteins and polynucleotides encoding them
03/02/2000WO1999058555A3 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues
03/02/2000WO1999057149A3 Compounds and methods for modulating nonclassical cadherin-mediated functions
03/02/2000WO1999053945A8 Neuron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration
03/02/2000WO1999045947A9 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases
03/02/2000WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
03/02/2000WO1999011605A8 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
03/02/2000DE19838848A1 Pyrrolizidinalkaloidfreie Petasites enthaltende Zusammensetzung Pyrrolizidinalkaloidfreie Petasites containing composition
03/02/2000DE19838636A1 Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein A carotenoid formulation comprising a mixture of beta-carotene, lycopene and lutein
03/02/2000CA2342162A1 Drug targeting
03/02/2000CA2341989A1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
03/02/2000CA2341673A1 Amelioration of apomorphine adverse effects
03/02/2000CA2341531A1 Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands
03/02/2000CA2341530A1 Carbamate and urea compositions and neurotrophic uses
03/02/2000CA2341400A1 Methods and compositions employing optically pure s(+) vigabatrin
03/02/2000CA2341370A1 Novel substituted triazole compounds
03/02/2000CA2341028A1 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000CA2340946A1 Muscarinic agonists and antagonists
03/02/2000CA2340928A1 Novel arylsulphonamides and analogues
03/02/2000CA2340884A1 49 human secreted proteins
03/02/2000CA2340327A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
03/02/2000CA2339871A1 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000CA2339860A1 Human cell signaling proteins (csig)
03/02/2000CA2339775A1 Vitamin d3 mimics
03/02/2000CA2339188A1 Isoxazolo¬4,5-d|pyrimidines as crf antagonists
03/01/2000EP0982400A1 Human glycine transporter
03/01/2000EP0982305A1 Indane-1-ol derivatives, process for their preparation and pharmaceutical compositions containing them
03/01/2000EP0982304A1 Piperidine derivatives having effects on serotonin related systems
03/01/2000EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
03/01/2000EP0982297A2 Process for the preparation of hydroxy-pyrrolidinyl hydroxamic acid derivatives being opioid kappa receptor agonists
03/01/2000EP0982030A2 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
03/01/2000EP0981969A1 Carotinoid compositions comprising a mixture of beta-carotene, lycopene and lutein
03/01/2000EP0981610A2 Compositions for treatment of disorders involving programmed cell death
03/01/2000EP0981538A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alp ha-diol-20-one 3-sulfate useful as progestins and cns disorders
03/01/2000EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors
03/01/2000EP0981516A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d?3 receptors
03/01/2000EP0981515A1 Piperidine derivatives as neurotransmitter re-uptake inhibitors
03/01/2000EP0981353A1 Facilitation of repair of neural injury with cm101/gbs toxin
03/01/2000EP0981349A1 Pregnan-3-ol-20-ones
03/01/2000EP0981348A1 The use of levobupivacaine in paediatric surgery
03/01/2000EP0981347A1 The use of levobupivacaine in facial surgery
03/01/2000EP0981334A1 Swallow tablet comprising paracetamol
03/01/2000EP0782573B1 Brefeldin a and analogs to improved synaptic transmission
03/01/2000EP0673374B1 Pharmaceutical composition containing bicyclic type compounds
03/01/2000EP0513387B1 Thiazole derivatives as active oxygen inhibitors
03/01/2000CN1246119A Pyrrolo [3,4-d] pyrimidinone derivatives and their use as medicaments
03/01/2000CN1246117A 1,2-dihydroindene or indoline derivatives
03/01/2000CN1246116A Sulphonamide derivatives, process for their preparation and their use as medicaments
03/01/2000CN1246111A Novel compound with analgesic effect
03/01/2000CN1246110A Arylpiperidinopropanol and arylpiperaznipropanol derivatives and pharmaceuticals containing the same
03/01/2000CN1245799A Preparation method of pyrrolidyl hydroxamic acid compound
03/01/2000CN1245710A Medicinal composition for curing sleepless and amnesia
03/01/2000CN1049817C Method for preparation of percutaneously absorbable drug composition
02/2000
02/29/2000US6031114 Process for pyrrolidinyl hydroxamic acid compounds
02/29/2000US6031099 Piperidine derivates having anxiolytic effect
02/29/2000US6031072 Compounds and methods for modulating cell adhesion
02/29/2000US6031007 A homogenous dental emulsion or microemulsion of local anesthetic in oil form, a surfactant having thermoreversible gelling properties, i.e. thickening when contacting mucous membranes, and water; pathological periodontal pockets; scale
02/29/2000US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse;
02/29/2000US6030976 Use of sulfonamides
02/29/2000US6030966 Heterocyclic compound and their use
02/29/2000US6030946 Reversible cysteine protease inhibitors
1 ... 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 ... 1833